Repligen Corp.

Repligen is a bioprocessing company focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The company's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS pre-packed columns, chromatography resins, ELISA kits), and filtration products (XCell ATF Systems, Sius? tangential flow filtration cassettes). The company's bioprocessing products are sold to life sciences companies and others. The Protein A ligands and growth factor products that the company manufactures are components of chromatography resins and cell culture media, respectively.
  • TickerRGEN
  • ISINUS7599161095
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders continue to be leadership. (ex. MTH, PHM, and MHO) • A number of Transportation Sector names are staging price and RS reversals, or remain leadership. (ex. XPO, JBLU, UAL, SKYW, AAL, DAL, UNP, JBHT, KNX, ODFL, LSTR, and SAIA) • Many Materials Sector names appear to be staging price and RS reversals. (ex. DOW, VVV, LYB, MLM, VMC, USCR, EMN, and CMC. )

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

1 director sold

A director at Repligen Corp sold 6,467 shares at 58.544USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders continue to be leadership. (ex. MTH, PHM, and MHO) • A number of Transportation Sector names are staging price and RS reversals, or remain leadership. (ex. XPO, JBLU, UAL, SKYW, AAL, DAL, UNP, JBHT, KNX, ODFL, LSTR, and SAIA) • Many Materials Sector names appear to be staging price and RS reversals. (ex. DOW, VVV, LYB, MLM, VMC, USCR, EMN, and CMC. )

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Gold is staging a massive breakout above the $1360 level. Major H&S bottoms can be seen across the group (ex, NEM, RGLD) • Energy related names are attempting to carve out reversals. We prefer the names that held up well during the Crude oil decline. (ex. HLX, PUMP, FTI, CKH, PSX) • A number of Biotech names are breaking out of bases and reflect RS leadership. (ex. OMCL, RGEN, INCY, and ANIP)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: Home builders and suppliers continue to outperform and one supplier, MHK, appears to be bottoming. A number of Financial names continue to plod up and to the right (e.g. AMP, AXP, MSCI, RNR) The Technology Sector remains leadership and many names continue to outperform (e.g. SEDG, SNPS, ADBE, TTEC, GPN, PYPL)

ResearchPool Subscriptions

Get the most out of your insights

Get in touch